Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab
Nicholas Costable, Zachary A. Borman, Jiayi Ji, Marla C. Dubinsky, Ryan C. Ungaro
Topics & Concepts
VedolizumabUstekinumabMedicineInternal medicineImmunogenicityInflammatory bowel diseaseTumor necrosis factor alphaAntibodyImmunologyInfliximabDiseaseInflammatory Bowel DiseaseBiosimilars and Bioanalytical MethodsRheumatoid Arthritis Research and Therapies